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ABSTRACT
Often the development of novel materials is not amenable to high-throughput or purely computa-
tional screening methods. Instead, materials must be synthesized one at a time in a process that
does not generate large amounts of data. One way this method can be improved is by ensuring that
each experiment provides the best improvement in both material properties and predictive modeling
accuracy. In this work, we study the effectiveness of active learning, which optimizes the order of
experiments, and meta learning, which transfers knowledge from one context to another, to reduce
the number of experiments necessary to build a predictive model. We present a novel multi-task
benchmark database of peptides designed to advance active, few-shot, and meta-learning methods
for experimental design. Each task is binary classification of peptides represented as a sequence
string. We find neither the query by committee nor uncertainty minimization active learning meth-
ods to be better than random choice of training points. The meta-learning method Reptile was found
to significantly improve average accuracy across multiple datasets. We find that combining meta-
learning with active learning methods offers inconsistent benefits.
Keywords Active Learning ·Machine Learning ·Meta-Learning · Peptide Modeling
1 Introduction
Although great strides have been made in predictive computational modeling where large datasets exist, the use of
computational modeling where data is scarce and/or expensive has been limited. Data expense and scarcity is the
norm in materials design. [1] Computer-aided design of materials often relies on physics-based predictive methods, [2,3]
which require no data, but cannot predict complex properties like activity of a drug or refractive index of a thin film.
Even if physics-based modeling is used, there is no clear mechanism to improve predictions as data is gathered in the
course of testing materials. Thus, human intuition is often the state-of-the-art for choosing which new materials to test
when there are small amounts of data.
Here we apply active learning to binary classification of peptides across a variety of binary tasks like predicting
solubility or activity against bacteria. We examine two standard active learning methods: query by committee (QBC) [4]
and uncertainty minimization [5] with supervised learning of a deep convolutional neural network. We also examine
meta-learning to see if there is a benefit in transferring knowledge from one task to another. We only allow our active
learners to choose from the dataset of labeled peptides (rather than generate new sequences), so that we can accurately
assess the selection during training. However, these methods are ultimately evaluated not based on the peptide chosen,
but the accuracy of the resulting trained model. The rationale is that there are many competing design constraints in
peptide design (e.g., synthetic feasibility, cost, bioavailability, etc) and thus it is better to have an accurate model than
a finite set of examples proposed to be active. The goal of this work is to assess active learning and meta-learning as
potential ways to improve iterative discovery of peptides in this setting.
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Active learning has a history as an extension to design of experiments, which is about choosing the optimal experiments
to do with limited resources. Our concern is a sequence of experiments where the results of the previous experiments
influence our decision of the next, whereas optimal design of experiments is about choosing the best experiment prior to
beginning, and assumes a linear model. Active learning is this process of choosing the next experiment optimally. [6] It
is sometimes called optimal experimental design, [7] targeted experiment design, [8] sequential design of hypotheses, [9]
optimal learning, [10] and artificial intelligence scientific discovery [11] depending on the goal and problem context.
Active learning is typically formulated as an optimization problem. [6] Consider N observation pairs xi, yi of features
and labels, respectively, with i ∈ [0, 1, . . . , N ] indicating the order of observation. Assume that yi is a class label and
xi is a feature vector of real numbers. We have a task model, Pθi(y|x), that assigns a probability to each class label
for a feature x and is defined by parameters θi, which are updated after each new observation. In this work Pθ is a
deep-learning convolutional neural network. θi is updated according to some training procedure after a new xi, yi pair
is observed. In active learning, we choose xi+1 from our fixed dataset of x, y pairs according to
xi+1 = argmax
xj
Aψ [xj , Pθi(yj |xj)] (1)
whereAψ(·) is a functional of the task model and possibly x. The j subscript only indicates that for a given xj we must
use the corresponding yj to evaluate the functional. Aψ(·) can be defined by parameters ψ, although it is normally
fixed. For example, Aψ(·) could be the most uncertain point, which gives
xi+1 = argmax
x
[1− Pθi(yˆ|x)] (2)
where yˆ is the most likely class label for x under Pθi .
[12] Aψ(·) is called the acquisition function or utility function
depending on the problem setting. [6]
Within this framework, there are a variety of approaches depending on the form of the task model and utility function.
If the task model is probabilistic, like above, utility functions which maximize information gain, [7,13] reduce model
uncertainty, [14] maximize expected model change, [6] or reduce model variance [15] can be chosen. Within variance re-
duction methods, there are so-called A-optimal, [15] D-optimal, [15,16] and E-optimal [17] approaches which minimize the
covariance matrix according to different assumptions. If the task model is non-parametric, Bayesian approaches are
well- suited. [8] One still has a choice of utility function and can, for example, maximize the expected model improve-
ment at each experiment. [16,18] Bayesian approaches can work with recent deep learning methods through Bayesian
convolutional neural networks [19] or through the hypothesized connection between dropout and neural network uncer-
tainty. [20]
If the task model is not stochastic but there is flexibility in parameter choice or multiple models to choose from, then
there are a variety of pooled or consensus active learning approaches. Query By Committee (QBC) is an active learn-
ing approach that maintains a committee of models and chooses the next experiment based on where the committee
disagrees most. [21] This “disagreement” is quantified using one of the various utility functions described above, for
each committee member, and combining the results in some way, e.g. using summation or taking the mean. There
are also active learning pool methods for specific model types. For example, k-nearest neighbor, [22] logistic regres-
sion, [23,24] and linear regression with noise. [25] One can also treat the choice of model as a probability distribution and
then the pool of models can be viewed as a stochastic or Bayesian model to use any of the previous utility functions.
There are active learning methods that are independent of the task model and instead find a characteristic set of
data. [26] This can be done by clustering the data, optimizing a function which describes local variance, [27] finding
regions of high uncertainty, [28] or by finding a characteristic subset of data called a “coreset” via submodular function
optimization. [22,29] These methods are closely related to semi-supervised learning, which tries to use unlabeled data to
improve a model when labeled data is sparse. [30,31]
Another closely related topic to active learning is Bayesian optimization or global optimization of black box func-
tions. There the goal is to optimize a function while evaluating it a minimum number of times. To connect this to
active learning described above, view the “expensive function” as the experiment. A surrogate stochastic model is
constructed, often through bootstraping or non-parametric models, and that surrogate model is used within an active
learning framework to reduce the number of the function evaluations. [32] Then active learning is applied so that each
function evaluation improves the maximum function value and/or understanding of the model. This method can be
equivalent to the variance reduction techniques discussed above if the same utility functions are chosen. [33] More
sophisticated active learning methods can be used with the surrogate model, including Gaussian process regression
and complex portfolios of acquisition (utility) functions. [34,35] A common critique of Bayesian optimization is that it
typically scales between O(n2) to O(n3), depending on approximations made, and struggles with high-dimensional
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surrogate models. However, this is not applicable here, since our goal is learning in systems with dozens of experi-
ments, not thousands. A recent overview on the application of Bayesian optimization to materials design can be found
in Frazier and Wang. [36]
An early example of active learning in chemistry can be found with van de Walle et al., [37] where a phase diagram was
explored using variance minimization active learning on cluster expansions. Active learning works well in general
with choosing cluster expansions via variance minimization. [38,39] More recently, Lookman et al. [40] explored elastic
properties with ab initio calculations using a Bayesian optimization technique (Efficient Global Optimization) to op-
timize the ratio of three metals. The authors applied the same method to design new piezoelectrics [41] with a four
dimensional design space. Gopakumar et al. [10] also showed how active learning methods that balance exploration
and exploitation can work well on 2 and 3 dimensional materials systems. This active learning approach to finding
compositions with Bayesian optimization is quickly gaining popularity in the material informatics community for
low-dimensional systems. [42–44]
Kim et al. [45] explored active learning methods to find polymers with a specific glass transition temperature. This is a
high-dimensional system because the polymers are represented with a variety of descriptors. It was made tractable by
treating a list of 731 possible polymers as known a priori. At each step the model evaluates all 731 possible polymers.
An earlier example using a fixed molecule set can also be found in Warmuth et al. [46] where candidate drug molecules
were selected from a vendor catalogue with a variance minimization active learning algorithm.
To avoid this difficulty of high dimensionality and ambiguity of representing molecular structures as vectors (although
see new work from Sanchez-Lengeling and Aspuru-Guzik [47], Blaschke et al. [48], Go´mez-Bombarelli et al. [49]), this
work focuses on peptides. Peptides are a natural fit as targets for experimental design driven by machine learning,
because they draw from the finite alphabet of 20 natural amino acids. They can be readily encoded as discrete vectors,
as opposed to the less well-defined space of all possible valid chemical structures for other purposes, for which more
specialized methods like autoencoders can be necessary. The easily-encoded amino acid sequence representation of
peptides also has a convenient parallel in existing machine learning methods for natural language processing, which is
already a developed sub-field of machine learning from which modeling techniques can be leveraged. [50]
Recently Tallorin et al. [51] explored the use of Bayesian optimization for de novo design of peptide substrates. Their
work is similar in that both this work and theirs used a sequence model with the goal of minimizing the number
of experiments required to train a model. The differences are that they were modeling with regression, allowed
for complete choice in sequence space, did not have a goal of creating accurate models, and did not use a deep
learning model but a Naı¨ve Bayes classifier. Their work is an experimentally validated demonstration that intelligently
designing experiments with predictive models can reduce the required number peptides that need to be synthesized
and tested.
Another topic explored in this work is meta-learning. Meta-learning is a technique for improving few-shot learning
across multiple tasks. The goal, in our nomenclature above, is to make the task model depend on hyperparameters ξ
that are trained to work well across multiple tasks. Then on a new task, using ξˆ, few new examples are required to
improve performance. Active learning and meta-learning are connected because both are concerned with maximizing
the value of data. As the goal is to minimize the number of experiments required for new systems, we find it natural to
consider this method on our dataset. Examples of meta-learning for accelerating task models can be found in transfer
learning, [52] few-shot learning, [53–55] and automated machine learning. [56] One application that has recently connected
active learning and meta-learning is in model free reinforcement learning. [57,58] Pang et al. [59] and Fang et al. [60] have
also explored the connection between active learning and meta-reinforcement learning.
2 Methods
Five past published databases were used to generate training datasets in this work: the Antimicrobial Peptide Database
(APD), [61] the collection of protein surface fragments from White et al., [62] the PROSO II database, [63] library hits
with activity against TULA-2 protein, [64] and library hits with activity against SHP-2. [65] The APD contains peptides
flagged with a variety of activities such as antibacterial, antifungal, antiviral, anticancer, and hemolytic activities. The
PROSO II databse contains peptides and proteins categorized as soluble or insoluble. The TULA-2 and SHP-2 libraries
contain fixed-width peptides optimized for binding to a specific target. Eight datasets were chosen from the APD: 1.
“antibacterial,” 2. “anticancer,” 3. “antifungal,” 4. “antiHIV,” 5. “antiMRSA,” 6. “antiparasital,” 7. “antiviral,” and 8.
“hemolytic.” All sequences above length 200 were excluded. This wide variety of tasks represents a range of modeling
goals in peptide research.
The task model is a deep convolutional neural network classifier, necessitating negative training examples as well as
positive. One corresponding negative training data set was generated for each positive data set. Two types of negative
3
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Positive Dataset Size Negative Datasets
antibacterial 2079 shp21, tula2, insoluble2, antifungal3, antiHIV, anticancer, fake
anticancer 183 shp2, tula2, insoluble, antifungal, antiHIV, antiparasital, antibacterial, fake
antifungal 891 shp2, tula2, insoluble, antiHIV, anticancer, antibacterial, fake
antiHIV 87 shp2, tula2, insoluble, antifungal, anticancer, antiparasital, antibacterial, fake
antiMRSA 119 shp2, tula2, insoluble, antiHIV, anticancer, antiparasital, fake
antiparasital 90 shp2, tula2, insoluble, antiHIV, anticancer, fake
antiviral 150 shp2, tula2, insoluble, antifungal, anticancer, antiparasital, antibacterial, fake
hemolytic 253 shp2, tula2, insoluble, human4, fake
soluble 7028 insoluble5
shp2 120 fake6
tula2 65 fake6
human 2880 insoluble, hemolytic, fake
Table 1: The positive and negative examples chosen for training the classifiers. Negative datasets were sampled to
be the same size as the positive datasets. 1 It is exceedingly rare to find antibacterial peptides, so it is assumed that
the SHP-2/Tula-2 binding peptides are not good examples of antibacterial peptides. 2 Insoluble peptides cannot be
successful antibacterial peptides. 3 Antifungal and antibacterial activity are different mechanisms, so it is unlikely that
a given peptide is both antifungal and antibacterial. 4 it is assumed that fragments of proteins found on surfaces of
proteins found in humans are not hemolytic (kill red blood cells). 5 No fake scrambled dataset is necessary because
there are known negative examples. 6 classifying SHP-2 and Tula-2 is in the context of fixed-length peptides so only
scrambled peptides with the same length are used for classification.
data were generated: fake scrambled data with amino acid distributions identical to the “soluble” dataset but length
distributions identical to the corresponding positive dataset, and samples from datasets which are expected to have no
intersection with positive examples (see Table 1. These are expected to be rather challenging negative examples, since
scrambled peptides likely have many physical properties of the positive examples. Generally, the non-intersecting
datasets are also naturally occurring peptides that likely are biologically relevant. To generate the fake scrambled
negative data set, a number of peptides were generated randomly, with lengths sampled from the same length range
as their respective positive set, and residues sampled from the frequency distribution of the soluble dataset. The
non-intersecting examples are shown in Table 1 along with rationale in the caption. To balance classes, the negative
datasets were sampled down to be the same size as the corresponding set of positive examples. A t-SNE projection of
each dataset in this work is shown in Figure 1.
Peptide sequences are encoded as one-hot vectors of dimensionN ×20 (withN the length of the peptide), where each
index in the second dimension corresponds to the index of the amino acid in the nth position in the alphabet of amino
acids: [A, R, N, D, C, Q, E, G, H, I, L, K, M, F, P, S, T, W, Y, V]. Activity was encoded as a one-hot label vector of
length 2, where [1, 0] indicates a positive label and [0, 1] indicates a negative label.
The task model structure is a convolutional neural network partially inspired by past work in peptide modeling. [66]
The model structure is shown schematically in Figure 2. The first layer of the neural network is a convolutional layer
with a weight matrix of dimension [W × A × K], where W and K conceptually represent peptide “motif widths”
and number of “motif classes,” respectively, and A is the length of the amino acid alphabet considered (20 for the
naturally-occurring peptides used here). The next layer is a mean pool layer, which captures which “motif class” is
most likely in the input peptide by pooling across the peptide’s length dimension, leaving a 1×K vector.
The output of the max pool layer is concatenated with the relative frequency of each amino acid in the input peptide
(1 × 20 vector) and standardized (0-1) sequence length. This is then fed to three fully-connected (FC) layers with
ReLU activation function and then to one FC layer with softmax activation for classification, ensuring the outgoing
vector of size 2 adds up to 1, since this vector is meant to represent the likelihood of assignment to the positive or
negative classes. The final output is compared with the true label vector (classification) or the true activity (regres-
sion), and loss is calculated as the cross-entropy between the two. The minimization algorithm used during training
was TensorFlow’s [67] Adam optimizer with parameters recommended in Kingma and Ba [68] and a learning rate of
0.001. This architecture is relatively simple compared to state-of-the art deep leanring for sequence prediction tasks of
peptides. Recently, Veltri et al. [69] developed a deep learning model for predicting antimicrobial activity. As our goal
is to explore active and meta-learning, we use a simpler architecture. Namely, we do not use embeddings, and we use
smaller and fewer filters, and fully-connected layers after features instead of a recurrent neural network.
The method of uncertainty minimization is designed to favor exploration to maximize information gained per training
iteration of a model. This is achieved by choosing a new training point based on some measure of the uncertainty
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Figure 1: t-SNE projection of the dataset used in this work. The figure shows that the fake datasets show significant
overlap with their counterparts. Some of the datasets appear to be more difficult to separate, like the soluble set.
Figure 2: Neural network structure for active learning. Here, Lmax is the maximum width of a peptide in the dataset
(though a convolution can use any length), K is the number of motif classets, and A is the length of the amino
acid alphabet. Peptides are first translated to a one-hot encoding (Lmax × A) and a vector of normalized amino acid
counts (1 ×N ). The output of the max pool layer is passed through one fully connected layer with ReLU activation,
then amino acid counts are appended to the output. This is then passed into two more fully connected layers with a
final output dimension of 2, for positive and negative class labels. Labels below neural network layers indicate the
dimensionality of the data as it passes through the layer.
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of the machine learning model used. In this sense, it is well-aligned with an eventual goal of automated experiment
selection, because it can minimize the number of necessary experiments to characterize a property space well. This,
in turn, would lead to a reduction in operating costs and time spent performing experiments.
For uncertainty minimization training, the model described previously was used, with W and K both chosen to be
6. Before training, model weights are randomly initialized. The model uncertainty is calculated as the variance of
the output vector of the neural network for each peptide. One peptide is then sampled, with probabilities of selection
for each peptide weighted by their respective variances under the current model parameters, i.e. p(1 − p). This is
different than Equation 1, where argmax is used instead of sampling. The chosen peptide is then used to train the
neural network for one training iteration, then an additional 16 training iterations are performed with batch size 16,
sampling uniformly from all previously-observed peptides for training input. Thus, in the first iteration the first point
is used for 50 training steps, then in the second, the first and second points are used an expected value of 12.5 times
each, etc. This process is repeated for 50 training epochs for one training run. To gather statistics, 30 training runs of
50 epochs each were performed for each dataset. We also investigated model performance after 100 training runs of 10
epochs, to evaluate the few-shot learning capability of the various combinations of active and meta-learning methods
used here.
The QBC method employed in this work uses the same approach as uncertainty minimization, but instead of a single
task model that is trained and used for selection, a committee of 10 models is used. The 9 additional models are all
structured in the same way as the model used in uncertainty minimization, but use different hyperparameters. They
differ in the dimensions of the weights matrix used in the convolution layer, having all combinations of 3 ≤ w ≤ 5
and 3 ≤ k ≤ 5 along with the W = 6, K = 6 model used in uncertainty minimization. In QBC, input data is
passed to each committee member (task model), and each one produces a prediction. The average variance among all
models is used as sampling weight for selecting a new training point, and training is performed in the same way as for
uncertainty minimization, with the same number of epochs and training runs.
To compare these active learning methods against a base case, we use two control training methods with the same
model as used for the uncertainty minimization method. The first control is a “baseline” Adam training, where the
model trains on all peptides for 5,000 steps with a batch size of 32. The second is a more direct comparison to the
active learning methods called “random” where peptides are chosen randomly and the model is trained in the same
way as in the active learning methods (batch size 16, 16 iterations, 50 epochs).
The meta-learning method used in this work is Reptile from Nichol et al. [70]. It is related to the the work by Finn
et al. [71], called model agnostic meta-learning. In our notation, the goal of meta-learning is to optimize the initial
parameters of the task model, θ0, to work well given a sampled task τ . P (τ) is taken to be uniform across our datasets.
θ0 is optimized by Adam optimization of a meta-objective function:
EP (τ) [L [U(ψ, θ0, τ)]] (3)
where τ is the dataset corresponding to a set (x, y), ψ are the parameters defining the active learning method Aψ(·),
and θ0 is the given initial task model parameters. L is the usual loss function and U is a stand-in for doing J steps of
active learning training with Aψ(·). The gradient of this meta-objective requires a Hessian, but Reptile approximates
this with a Taylor expansion. In this work J = 16, meaning we train with active learning on 16 peptides each time with
a batch size of 16. 2,500 meta-learning iterations were done and then early stopping was used to prevent overfitting.
This was done on an 80% split of the left-out dataset and then results were reported on the 20% remaining sequences
of the left-out dataset.
AUC values and accuracies are reported on withheld data which was 20% of the dataset size. Training curves are
shown in Figures 3 and 6, and exact final values for withheld set accuracy and ROC AUC values are reported in the
Supporting Information in Tables S1-S4. The accuracies and AUCs reported here are on the withheld dataset from
training. During meta-learning, the location of active/inactive labels (first or second index) was swapped between
tasks to prevent over-fitting to active being in one position or another. This gives minimal zero-shot accuracy, but
helps illustrate the rate of training, as shown in Figures 3 and 6. The minimized loss function was cross entropy
between label probabilities and true labels. Error bars and individual traces are different due to split differences of
data and random number initial parameter seeds.
3 Results and Discussion
Figure 3 shows the active learning, meta-learning, and baseline results across the twelve datasets for the uncertainty
minimization active learning strategy. The baseline results (gray) show that the convolutional neural network provides
reasonable results across the range of modeling tasks despite its simple architecture. The solubility task showed the
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worst overall performance. Solubility classification is challenging because many of the training examples are folded
proteins, requiring long-range sequence correlations to model properly. Our simple convolutional neural network
has an accuracy of 0.59, which is within the reported range of current state-of-the-art solubility models (from 0.52-
0.77). [72,73] Figure 3 also shows the comparison of choosing peptides randomly and choosing peptides for which the
model has maximum uncertainty (uncertainty minimization). Uncertainty minimization (blue line) is not better than
choosing randomly (dashed green) in general. It is sometimes worse and sometimes better in the long term, but for
few-shot learning of up to 10 training examples, it is not significantly different from random choice (see Figure 7).
To assess the effect of meta-learning on reducing experiment number, it was evaluated both alone and in combination
with active learning. Results from combining meta-learning with uncertainty minimization are shown in Figure 3.
Meta-learning consistently improves initial gains in accuracy, except in the soluble, SHP-2 and TULA-2 tasks. This
is likely because these tasks are quite different from the other nine, so feature re-use is less important. Combining
uncertainty minimization with meta-learning only sometimes increases accuracy over random choice, but significantly
improves few-shot accuracy on average after 10 training examples (see Figure 7). In some datasets, final accuracy
approaches or even exceeds baseline levels with less than 25 examples, whereas the baseline is trained on all data.
This demonstrates the advantage of using meta-learning.
Receiver operator characteristic (ROC) curves provide an accounting of the balance between type I and type II error.
This is important for peptide activity because, due to the large design space, false positives are more detrimental to a
model’s usefulness. The area under curve (AUC) of a ROC curve gives a scalar representing the quality of the ROCs.
Note that here we enforced balanced classes (same number of positive/negative examples in the training set). This
ensures that accuracy and ROC are good measures of performance, while other metrics become necessary in cases
with unbalanced training sets. The ROC AUCs are reported in the Supporting Information in Tables S1 and S2 and
Figure S1. As observed in Figures 3 and 7, there is no significant gain to be had in using uncertainty minimization
active learning. Also, 50 examples is not enough to match the baseline models without meta-learning. The source of
variance in this work is because there are many ways to choose 50 peptides from the datasets, the tasks of the datasets
are disparate, and some datasets are small. Significant exceptions are the SHP-2 and soluble datasets, which show
poor performance with limited examples relative to baseline models. In particular, SHP-2 seems to require the full
dataset to achieve good accuracy. This may be due to the importance of motifs in this dataset, [74] and lack of feature
re-use between datasets due to its unique task (binding affinity with specific enzyme).
The QBC training results are reported in Figure 6. QBC does not consistently provide better performance than ran-
dom choice or uncertainty minimization. QBC significantly improves with meta-learning. As shown in Figure 7,
QBC seems to have the best few-shot and final performance when combined with meta-learning, though uncertainty
minimization is as good for few-shot only. Supporting Information contains tabulated AUCs and accuracies in Tables
S1-S8.
Overall, meta-learning usually improves accuracy when combined with active learning methods across these datasets,
especially , as shown in Figure 7. Recent analysis of meta-learning has shown mixed results across tasks. Raghu
et al. [75] showed that model agnostic meta-learning methods like Reptile only learn to re-use features across tasks.
To assess how feature re-use can be applicable in these dataset, we performed a basic sensitivity analysis in Figure 4
which gives insight into the various features used in the modeling. Figure 4 shows the features for the baseline model
on the antibacterial dataset and the zero-shot features for meta-learning. Note that all motif frequencies are 1.0 since
this is the meta-learned parameters, not a realization of training. The results show that meta-learning does not have the
same features found in the baseline model, although some of the important amino acids are shared (N, C, H). Some of
the amino acids within the motifs are shared, but they are not identical.
To ensure our conclusions about meta-learning and QBC being preferred for peptide design are robust, we explored
four alternative model choices. These are shown in Figure 5 for only the antibacterial task (although meta-learning
traces were trained on all but antibacterial). The second subplot is ablation of the motif convolutions, i.e. using only
amino acid count vectors for training. Without the motifs, accuracy is roughly the same, and only the combination of
QBC with meta-learning is advantageous over random choice. Training with only motifs (convolutions) and no amino
acid counts reduces performance in general and entirely removes the benefits of meta-learning, active learning, and the
combination of the two. Using the original model structue but switching from a cross-entropy loss to absolute error
loss reduces accuracy for all methods. The last plot shows what happens if we remove the label swapping during meta-
learning, which is used to reduce over-fitting to “active” peptides. Zero-shot performance is improved, due to good
correlation of activity in peptides across tasks. Meta-learning is preferred in this setting, when it is known that the class
labels of active vs inactive can be re-used across tasks. These results indicate that the benefits of meta-learning paired
with active learning can be sensitive to the model structure used. In particular, if the chosen loss function is poor, few-
shot accuracy improvement may be impossible. The benefits of meta-learning combined with active learning seem
7
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Figure 3: Training curves of uncertainty minimization active learning compared with baseline (gray) trained across all
data points and randomly choosing examples. The y-axis is accuracy on withheld data. Light traces are individual 30
runs and the dark trace is median (only one set of traces is shown). Each run has a different train/withheld split and
random number generator seeds. Each subplot is a different task.
Figure 4: Features across tasks for baseline model. The barplot shows the partial derivative of probability of activity
with respect to amino acid count averaged across training data. This gives importance for assigning label. The
right side of the plots shows the maximum magnitude weight in the convolution, which roughly corresponds to most
attended motif in the sequence. The y-axis label on the right side shows the frequency of this motif across 50 training
iterations. “Z” is the normalized length of the peptide.
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Figure 5: Training curves for different model choices, using the Antibacterial dataset. Baseline is the same in each
panel and the baseline subplot is the model as presented in text. “No Motifs” has the convolution layers removed, “No
Counts” has amino acid counts removed, “Abs Loss” uses an absolute difference loss instead of cross-entropy, and
“No Label Swap” means that labels weren’t swapped during meta-learning so that zero-shot accuracy is maximized.
These results show that meta-learning is not always better, but is consistently a good choice for few-shot learning.
Figure 6: Training curves of uncertainty minimization active learning with and without Reptile meta-learning, com-
pared with baseline (gray) trained across all data points and training with randomly-chosen examples with and without
meta-learning. The y-axis is accuracy on withheld data. Light traces are the 50 individual runs and the dark trace is the
median. Each run has a different train/withheld split and random number generator seeds. Each subplot is a different
task which was withheld during meta-learning. Meta-learning offers inconsistent improvements, while active learning
consistently offers no improvements over random, unless paired with meta-learning (though still not consistently).
9
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Figure 7: Box-and-whisker plot comparing average accuracy values after 10 and 50 training examples across all
twelve datasets for five different methods explored in this work. Asterisks indicate statistically significant difference
(p ≤ 0.05) in mean accuracy, calculated using Wilcoxon’s signed ranks test among the twelve average accuracy val-
ues compared between two methods. Meta-learning significantly improves few-shot performance over uncertainty
minimization or QBC alone when combined with these active learning methods, but only ML+QBC shows signifi-
cant performance improvement after 50 training examples. This indicates that meta-learning can be a good tool for
increasing few-shot learning in settings where data is scarce. See Tables S7 and S8 for tables of all possible p-value
pairs.
to depend on the neural network features, as evidenced by the difference between the “No Motifs” and “No Counts”
subplots of Figure 5.
We assess statistical significance in Figure 7. The box-and-whisker plots show average accuracy values for the 10-
example and 50-example training runs described in the Methods section. We performed Wilcoxon’s signed ranks
test on the 12 training accuracy values for a given method, comparing between all possible pairs of the six methods
explored here, obtaining p-valuesfor each pair. Asterisks are shown in Figure 7 for pairs with p ≤ 0.05. Methods with
no asterisk were not significantly different. Exact values for all p-values for accuracy can be found in the Supporting
Information in Tables S7 and S8. We performed a similar analysis for the average AUC values for each method, also
found in the Supporting Information in Figure S1 with p-values in Tables S5 and S6. We can see from Figure 7 that
after 50 training examples, nearly all the methods explored here are not significantly different on average from random
choice (with or without meta-learning). In the few-shot case, with only 10 training examples, the differences between
methods are more pronounced. In this case, combining meta-learning with either uncertainty minimization or QBC
yields significantly better average accuracy than either active learning method alone. This supports the hypothesis
that meta-learning can enhance the accuracy of few-shot learning across multiple tasks, even for a relatively simple
convolutional neural network.
4 Conclusions
This work has presented a dataset of 12 different peptide classification tasks, and explored active learning and meta-
learning strategies for predicting peptide activity on them. The simple deep convolutional neural network used here
offers greater than 85% accuracy across all tasks except soluble, which was within reported ranges for other state-of-
the-art models. We expect more complex models with attention, more layers, and long-range interactions in sequence
space could improve the accuracy. The two active learning strategies explored here were not found to provide signif-
icant improvements over sampling peptides randomly. Meta-learning was found to improve few-shot accuracy with
10 training examples only when combined with active learning. Here, every meta-learning method (random choice,
uncertainty minimization, and QBC) performed significantly better on average than uncertainty minimization. Both
meta-learning with uncertainty minimization and meta-learning with QBC were significantly better than either active
learning srategy alone. After 50 training examples, only meta-learning with QBC was found to significantly increase
average accuracy over random choice, indicating that the benefits of meta-learning are short-lived. These conclusions
10
Iterative Peptide Modeling with Active Learning and Meta-Learning A PREPRINT
also hold in the zero-shot learning setting, but model ablation shows that they are dependent on loss choice and model
features. This work provides a new peptide multi-task dataset and benchmark results for standard active learning and
meta-learning methods.
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Baseline Random QBC Umin ML+Random ML+QBC ML+Umin
Antibacterial 0.94 0.86± 0.03 0.86± 0.10 0.89± 0.02 0.87± 0.05 0.85± 0.12 0.85± 0.13
Anticancer 0.86 0.85± 0.03 0.79± 0.18 0.79± 0.13 0.87± 0.03 0.85± 0.03 0.84± 0.06
Antifungal 0.92 0.85± 0.02 0.83± 0.07 0.86± 0.02 0.84± 0.03 0.84± 0.03 0.87± 0.02
Anti-HIV 0.86 0.86± 0.08 0.75± 0.12 0.85± 0.16 0.78± 0.05 0.80± 0.06 0.87± 0.04
Anti-MRSA 1.00 0.95± 0.02 0.95± 0.03 0.93± 0.19 0.96± 0.03 0.96± 0.03 0.94± 0.05
Antiparasital 0.89 0.95± 0.05 0.93± 0.13 0.94± 0.16 0.93± 0.03 0.97± 0.02 0.96± 0.02
Antiviral 0.85 0.83± 0.05 0.78± 0.10 0.81± 0.19 0.74± 0.05 0.87± 0.05 0.81± 0.14
Hemolytic 0.99 0.99± 0.00 0.92± 0.21 0.88± 0.24 0.98± 0.01 0.97± 0.06 0.93± 0.14
Soluble 0.63 0.53± 0.02 0.53± 0.03 0.53± 0.02 0.53± 0.02 0.53± 0.03 0.52± 0.02
SHP-2 0.97 0.87± 0.04 0.87± 0.04 0.89± 0.02 0.91± 0.05 0.90± 0.03 0.86± 0.04
TULA-2 0.90 0.86± 0.05 0.91± 0.03 0.88± 0.04 0.95± 0.02 0.91± 0.04 0.95± 0.03
Human 0.94 0.89± 0.01 0.84± 0.19 0.82± 0.20 0.89± 0.02 0.90± 0.02 0.89± 0.01
Table S1: Area under curve (AUC) for receiver operator characteristic curves for classifiers trained on 50 datapoints
with different active learning methods on different datasets. Baseline was trained on all data, whereas others saw 50
peptides according to their active learning strategy. Errors are computed from standard deviation across 100 trials
on different data splits and random sampling in active learning strategy. Umin is uncertainty minimization, ML is
meta-learning, and QBC is query by committee.
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Baseline Random QBC Umin ML+Random ML+QBC ML+Umin
Antibacterial 0.94 0.84± 0.01 0.83± 0.01 0.74± 0.21 0.84± 0.01 0.80± 0.11 0.83± 0.02
Anticancer 0.86 0.87± 0.15 0.88± 0.01 0.77± 0.19 0.80± 0.03 0.84± 0.05 0.90± 0.02
Antifungal 0.92 0.81± 0.12 0.79± 0.20 0.73± 0.24 0.84± 0.02 0.82± 0.02 0.75± 0.24
Anti-HIV 0.86 0.89± 0.14 0.76± 0.22 0.79± 0.28 0.86± 0.13 0.79± 0.15 0.85± 0.13
Anti-MRSA 1.00 1.00± 0.01 0.96± 0.17 0.84± 0.30 0.92± 0.01 0.95± 0.01 0.95± 0.01
Antiparasital 0.89 0.94± 0.17 0.93± 0.25 0.91± 0.24 0.90± 0.02 0.95± 0.02 0.95± 0.01
Antiviral 0.85 0.88± 0.09 0.75± 0.14 0.78± 0.20 0.86± 0.14 0.84± 0.13 0.82± 0.13
Hemolytic 0.99 0.94± 0.05 0.82± 0.24 0.89± 0.21 0.81± 0.10 0.76± 0.18 0.85± 0.12
Soluble 0.63 0.51± 0.03 0.50± 0.02 0.50± 0.03 0.51± 0.02 0.51± 0.02 0.51± 0.03
SHP-2 0.97 0.66± 0.13 0.77± 0.08 0.69± 0.11 0.61± 0.11 0.69± 0.17 0.58± 0.22
TULA-2 0.90 0.71± 0.09 0.80± 0.09 0.79± 0.14 0.60± 0.16 0.72± 0.15 0.66± 0.16
Human 0.94 0.84± 0.13 0.83± 0.18 0.80± 0.23 0.87± 0.01 0.85± 0.00 0.87± 0.01
Table S2: Area under curve (AUC) for receiver operator characteristic curves for classifiers trained on 10 datapoints
with different active learning methods on different datasets. Baseline was trained on all data, whereas others saw
10 peptides according to their active learning strategy. Errors are computed from standard deviation across 30 trials
on different data splits and random sampling in active learning strategy. Umin is uncertainty minimization, ML is
meta-learning, and QBC is query by committee.
Baseline Random QBC Umin ML+Random ML+QBC ML+Umin
Antibacterial 0.88 0.78± 0.04 0.78± 0.08 0.81± 0.02 0.80± 0.04 0.80± 0.03 0.79± 0.09
Anticancer 0.82 0.79± 0.04 0.78± 0.07 0.76± 0.08 0.80± 0.05 0.82± 0.02 0.78± 0.06
Antifungal 0.87 0.77± 0.05 0.78± 0.04 0.81± 0.02 0.76± 0.04 0.80± 0.03 0.82± 0.03
Anti-HIV 0.84 0.80± 0.08 0.79± 0.05 0.79± 0.09 0.71± 0.05 0.85± 0.05 0.82± 0.04
Anti-MRSA 0.96 0.90± 0.03 0.95± 0.02 0.94± 0.12 0.95± 0.04 0.95± 0.02 0.93± 0.01
Antiparasital 0.89 0.89± 0.07 0.91± 0.08 0.91± 0.11 0.90± 0.03 0.90± 0.03 0.94± 0.03
Antiviral 0.76 0.75± 0.06 0.74± 0.04 0.80± 0.11 0.69± 0.05 0.77± 0.04 0.76± 0.08
Hemolytic 0.98 0.98± 0.01 0.91± 0.12 0.90± 0.12 0.95± 0.01 0.96± 0.03 0.94± 0.07
Soluble 0.59 0.52± 0.02 0.51± 0.01 0.52± 0.02 0.52± 0.02 0.52± 0.02 0.51± 0.02
SHP-2 0.90 0.78± 0.04 0.82± 0.05 0.80± 0.04 0.77± 0.11 0.79± 0.09 0.77± 0.07
TULA-2 0.83 0.77± 0.06 0.81± 0.05 0.81± 0.05 0.85± 0.10 0.82± 0.05 0.85± 0.05
Human 0.89 0.82± 0.03 0.85± 0.07 0.80± 0.12 0.83± 0.03 0.84± 0.03 0.84± 0.03
Table S3: Final training accuracy values for classifiers trained with different active learning methods on different
datasets. Baseline was trained on all data, whereas others saw 50 peptides according to their active learning strategy.
Errors are computed from standard deviation across 30 trials on different data splits and random sampling in active
learning strategy. Umin is uncertainty minimization, ML is meta-learning, and QBC is query by committee.
Baseline Random QBC Umin ML+Random ML+QBC ML+Umin
antibacterial 0.88 0.74± 0.10 0.75± 0.06 0.66± 0.13 0.79± 0.03 0.73± 0.10 0.79± 0.06
anticancer 0.82 0.77± 0.13 0.79± 0.10 0.71± 0.11 0.76± 0.08 0.81± 0.07 0.86± 0.02
antifungal 0.87 0.71± 0.12 0.71± 0.14 0.67± 0.14 0.79± 0.06 0.78± 0.06 0.74± 0.14
anti-HIV 0.84 0.71± 0.19 0.73± 0.15 0.75± 0.15 0.79± 0.11 0.77± 0.10 0.79± 0.13
anti-MRSA 0.96 0.93± 0.13 0.92± 0.12 0.82± 0.15 0.87± 0.07 0.95± 0.01 0.93± 0.02
antiparasital 0.89 0.86± 0.15 0.81± 0.16 0.83± 0.15 0.85± 0.11 0.92± 0.08 0.92± 0.02
antiviral 0.76 0.73± 0.15 0.64± 0.11 0.71± 0.10 0.77± 0.09 0.79± 0.08 0.77± 0.09
hemolytic 0.98 0.79± 0.11 0.70± 0.15 0.79± 0.13 0.79± 0.09 0.75± 0.11 0.85± 0.02
soluble 0.59 0.50± 0.01 0.50± 0.01 0.50± 0.01 0.50± 0.01 0.51± 0.01 0.50± 0.02
SHP-2 0.90 0.51± 0.02 0.51± 0.03 0.51± 0.03 0.50± 0.00 0.50± 0.00 0.51± 0.04
TULA-2 0.83 0.51± 0.04 0.52± 0.05 0.51± 0.05 0.50± 0.00 0.50± 0.00 0.50± 0.00
human 0.89 0.83± 0.07 0.80± 0.12 0.77± 0.16 0.83± 0.09 0.81± 0.09 0.83± 0.09
Table S4: Final training accuracy values for classifiers trained with different active learning methods on different
datasets. Baseline was trained on all data, whereas others saw 10 peptides according to their active learning strategy.
Errors are computed from standard deviation across 100 trials on different data splits and random sampling in active
learning strategy. Umin is uncertainty minimization, ML is meta-learning, and QBC is query by committee.
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Random Umin QBC ml+random ML+Umin ML+QBC
Random N/A 0.5303 0.7537 0.8139 0.8753 0.04139
Umin 0.5303 N/A 0.3078 0.3465 0.1361 0.0186
QBC 0.7537 0.3078 N/A 0.4802 0.3078 0.01206
ML+Random 0.8139 0.3465 0.4802 N/A 0.9375 0.2094
ML+Umin 0.8753 0.1361 0.3078 0.9375 N/A 0.2094
ML+QBC 0.04139 0.0186 0.01206 0.2094 0.2094 N/A
Table S5: Area under curve (AUC) p-values between different methods after training on 50 peptides. These p-values
were calculated using Wilcoxon’s signed ranks test among the twelve average AUC values given by the corresponding
pair of methods. Bold indicates significance (p ≤ 0.05).
Random Umin QBC ml+random ML+Umin ML+QBC
Random N/A 0.01502 0.1167 0.02806 0.03417 0.1823
Umin 0.01502 N/A 0.1167 0.5303 0.2721 0.1579
QBC 0.1167 0.1167 N/A 0.8139 0.6379 0.6379
ML+Random 0.02806 0.5303 0.8139 N/A 0.5829 0.8139
ML+Umin 0.03417 0.2721 0.6379 0.5829 N/A 0.8139
ML+QBC 0.1823 0.1579 0.6379 0.8139 0.8139 N/A
Table S6: Area under curve (AUC) p-values between different methods after training on 10 peptides. These p-values
were calculated using Wilcoxon’s signed ranks test among the twelve average AUC values given by the corresponding
pair of methods. Bold indicates significance (p ≤ 0.05).
Random Umin QBC ml+random ML+Umin ML+QBC
Random N/A 0.3078 0.4802 1.0 0.1167 0.007649
Umin 0.3078 N/A 1.0 0.6379 0.3078 0.2721
QBC 0.4802 1.0 N/A 0.5303 0.2094 0.04986
ML+Random 1.0 0.6379 0.5303 N/A 0.3078 0.02806
ML+Umin 0.1167 0.3078 0.2094 0.3078 N/A 0.3882
ML+QBC 0.007649 0.2721 0.04986 0.02806 0.3882 N/A
Table S7: Final training accuracy p-values between different methods after training on 50 peptides. These p-values
were calculated using Wilcoxon’s signed ranks test among the twelve average accuracy values given by the corre-
sponding pair of methods. Bold indicates significance (p ≤ 0.05).
Random Umin QBC ml+random ML+Umin ML+QBC
Random N/A 0.07119 0.4328 0.8753 0.0186 0.1579
Umin 0.07119 N/A 0.4802 0.02291 0.007646 0.02806
QBC 0.4328 0.4802 N/A 0.1167 0.009633 0.03417
ML+Random 0.8753 0.02291 0.1167 N/A 0.05046 0.7989
ML+Umin 0.0186 0.007646 0.009633 0.05046 N/A 0.2477
ML+QBC 0.1579 0.02806 0.03417 0.7989 0.2477 N/A
Table S8: Final training accuracy p-values between different methods after training on 10 peptides. These p-values
were calculated using Wilcoxon’s signed ranks test among the twelve average accuracy values given by the corre-
sponding pair of methods. Bold indicates significance (p ≤ 0.05).
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Figure S1: Box-and-whisker plot comparing average AUC values after 10 and 50 training examples across all twelve
datasets for five different methods explored in this work. Asterisks indicate statistically significant difference (p ≤
0.05) in mean AUC, calculated using Wilcoxon’s signed ranks test among the twelve average AUC values compared
between two methods.
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